MAP3K9 and neoplasm: Since NSC14465 exhibits comparable inhibitory effects against both the kinase activities of MLK1 (38% inhibition) and MLK3 (18% inhibition) (~twofold difference, Figure 3A), the anti-tumor effects of NSC14465 might depend on the relative abundance and activities of the MLK family members in tumor cells.